Aptamers & antidotes

Physicians would like to have pinpoint control over drugs they administer in order to minimize the drugs' toxic effects, but this is rarely the case. To address the problem, scientists at Duke University Medical Center have taken advantage of the propensity of nucleic acids to bind their complementary

Read the full 482 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE